"The Ministry of Health has registered the vaccine" CoviVac ", and we plan that within the third phase, in April this year, we will begin clinical trials of our vaccine for children and for people over 60 years old," TASS quotes him.
On February 20, the KoviVac vaccine was registered in Russia.
In early February, the State Research Center for Virology and Biotechnology "Vector" completed post-registration clinical studies of the second Russian vaccine against COVID-19 "EpiVacCorona" among the elderly.